logo

For the Inventor, By the Inventor

Helsinki, Finland

Licentia, Ltd.


USPTO Granted Patents = 20

% Expired Patents = 60.0



Forward Citations = 152

Loading Chart...
Loading Chart...

65 inventors (with patents filed for the assignee):

goldMedal Kari Alitalo (10 out of 72 patents)

silverMedal Ulf Eriksson (3 out of 43 patents)

bronzeMedal Mart Saarma (3 out of 23 patents)

4.  Markku Michael Jeltsch (3 out of 10 patents)

5.  Carl-Henrik Heldin (2 out of 40 patents)

6.  Katri Pajusola (2 out of 9 patents)

7.  Marko Uutela (2 out of 5 patents)

8.  Kalle Saksela (1 out of 5 patents)

9.  Raimo Tuominen (1 out of 5 patents)

10.  Maria Lindahl (1 out of 5 patents)

11.  Petro Suvanto (1 out of 9 patents)

12.  Juha Lauren (1 out of 4 patents)

13.  Tonis Timmusk (1 out of 4 patents)

14.  Päivi Lindholm (1 out of 4 patents)

15.  Seppo Ylä-Herttuala (1 out of 3 patents)


20 patents:

1. 8029984 - Materials and methods for colorectal cancer screening, diagnosis and therapy (2011-10-04),
2. 7572616 - Alternative oxidase and uses thereof (2009-08-11),
3. 7488588 - Compounds related to or derived from GFR α4 and their use (2009-02-10),
4. 7452969 - Neurotrophic factor protein and uses thereof (2008-11-18),
5. 7414023 - Peptide ligands for prostate specific antigen (2008-08-19),
6. 7355022 - Gene functionally related to dyslexia (2008-04-08),
7. 7341996 - Processed vascular endothelial growth factor-B polypeptides (2008-03-11),
8. 7309604 - Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins (2007-12-18),
9. 7160991 - Vascular endothelial growth factor polypeptides (2007-01-09),
10. 7148037 - Platelet-derived growth factor D, DNA coding therefor, and uses thereof (2006-12-12),
11. 7125714 - Progenitor cell materials and methods (2006-10-24),
12. 7105481 - Method for stimulating connective tissue growth or wound healing (2006-09-12),
13. 7034105 - FLT4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy (2006-04-25),
14. 6974816 - Combination for the treatment of endothelial damage (2005-12-13),
15. 6965010 - Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins (2005-11-15),
Licentia, Ltd. is a Helsinki-based company specializing in the development and commercialization of innovative technologies across various sectors. The organization focuses on creating advanced solutions in fields such as software development, telecommunications, and digital services. With a commitment to research and development, Licentia aims to enhance efficiency and effectiveness in its target markets, contributing to the evolution of technology in Finland and beyond.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Licentia, Ltd.
20 Patents

#60 in Helsinki

#169 in Finland

#31,196 in the World

Helsinki, FI
Helsinki, Finland

Licentia, Ltd.

Forward Citations = 152

65 inventors:

goldMedal Kari Alitalo (10 out of 72 patents)

silverMedal Ulf Eriksson (3 out of 43 patents)

bronzeMedal Mart Saarma (3 out of 23 patents)

4.  Markku Michael Jeltsch (3 out of 10 patents)

5.  Carl-Henrik Heldin (2 out of 40 patents)

Please report any incorrect information to [email protected]
Loading…